DLK1 regulates whole-body glucose metabolism: A negative feedback regulation of the osteocalcin-insulin loop

Diabetes

Volumn 64, Issue 9, 2015, Pages 3069-3080

  Abdallah, Basem M ^a   Ditzel, Nicholas ^a   Laborda, Jorge ^b   Karsenty, Gerard ^c   Kassem, Moustapha ^a,d,e  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d University of Copenhagen   (Denmark)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA LIKE 1 PROTEIN; GLUCOSE; INSULIN; OSTEOCALCIN; PROTEIN; UNCLASSIFIED DRUG; DLK1 PROTEIN, MOUSE; MESSENGER RNA; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEEDBACK SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; OSTEOBLAST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; 3T3 CELL LINE; ANIMAL; GENETICS; HYPOGLYCEMIA; INSULIN RESISTANCE; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANIMALS; FEEDBACK, PHYSIOLOGICAL; GLUCOSE; HYPOGLYCEMIA; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; NIH 3T3 CELLS; OSTEOBLASTS; OSTEOCALCIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84941233924     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1642     Document Type: Article

References (49)

1. Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010;142:296-308
2. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130:456-469
3. Oury F, Ferron M, Huizhen W, et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest 2013;123:2421-2433
4. Fulzele K, Riddle RC, DiGirolamo DJ, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010;142:309-319
5. Wei J, Ferron M, Clarke CJ, et al. Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest 2014;124:1-13
6. Rached M-T, Kode A, Silva BC, et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest 2010;120:357-368
7. Yoshizawa T, Hinoi E, Jung DY, et al. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest 2009;119:2807-2817
8. Abdallah BM, Kassem M. New factors controlling the balance between osteoblastogenesis and adipogenesis. Bone 2012;50:540-545
9. Laborda J. The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol Histopathol 2000;15:119-129
10. Jensen CH, Krogh TN, Højrup P, et al. Protein structure of fetal antigen 1 (FA1). A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2. Eur J Biochem 1994;225:83-92
11. Smas CM, Sul HS. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993;73:725-734
12. Sul HS, Smas C, Mei B, Zhou L. Function of pref-1 as an inhibitor of adi-pocyte differentiation. Int J Obes Relat Metab Disord 2000;24(Suppl. 4):S15-S19
13. Abdallah BM, Ditzel N, Mahmood A, et al. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice. J Bone Miner Res 2011;26:1457-1471
14. Abdallah BM, Jensen CH, Gutierrez G, Leslie RG, Jensen TG, Kassem M. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1. J Bone Miner Res 2004;19:841-852
15. Abdallah BM, Bay-Jensen A-C, Srinivasan B, et al. Estrogen inhibits Dlk1/FA1 production: a potential mechanism for estrogen effects on bone turnover. J Bone Miner Res 2011;26:2548-2551
16. Fazeli PK, Bredella MA, Misra M, et al. Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia ner-vosa. J Clin Endocrinol Metab 2010;95:407-413
17. Aronis KN, Kilim H, Chamberland JP, Breggia A, Rosen C, Mantzoros CS. Preadipocyte factor-1 levels are higher in women with hypothalamic amenorrhea and are associated with bone mineral content and bone mineral density through a mechanism independent of leptin. J Clin Endocrinol Metab 2011;96:E1634-E1639
18. Lee K, Villena JA, Moon YS, et al. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest 2003;111:453-461
19. Villena JA, Choi CS, Wang Y, et al. Resistance to high-fat diet-induced obesity but exacerbated insulin resistance in mice overexpressing preadipocyte factor-1 (Pref-1): a new model of partial lipodystrophy. Diabetes 2008;57:3258-3266
20. Barbu A, Hedlund GP, Lind J, Carlsson C. Pref-1 and adipokine expression in adipose tissues of GK and Zucker rats. Mol Cell Endocrinol 2009;299:163-171
21. Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 1998;273:35299-35306
22. Andries A, Niemeier A, Støving RK, et al. Serum levels of fetal antigen 1 in extreme nutritional states. ISRN Endocrinol 2012;2012:592648
23. O'Connell J, Lynch L, Hogan A, Cawood TJ, O'Shea D. Preadipocyte factor-1 is associated with metabolic profile in severe obesity. J Clin Endocrinol Metab 2011;96:E680-E684
24. Raghunandan R, Ruiz-Hidalgo M, Jia Y, et al. Dlk1 influences differentiation and function of B lymphocytes. Stem Cells Dev 2008;17:495-507
25. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 2004;145:667-678
26. Carter JD, Dula SB, Corbin KL, Wu R, Nunemaker CS. A practical guide to rodent islet isolation and assessment. Biol Proced Online 2009;11:3-31
27. Abdallah BM, Ding M, Jensen CH, et al. Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone. Endocrinology 2007;148:3111-3121
28. Qiu W, Hu Y, Andersen TE, et al. Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C/EBP. J Biol Chem 2010;285:14438-14449
29. Ding M, Danielsen CC, Hvid I. Age-related three-dimensional microarchitectural adaptations of subchondral bone tissues in guinea pig primary osteoarthrosis. Calcif Tissue Int 2006;78:113-122
30. Dempster DW, Compston JE, Drezner MK, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2013;28:2-17
31. Pi M, Wu Y, Quarles LD. GPRC6A mediates responses to osteocalcin in b-cells in vitro and pancreas in vivo. J Bone Miner Res 2011;26:1680-1683
32. Kajimura D, Lee HW, Riley KJ, et al. Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1 [published correction appears in Cell Metab 2014;19:891]. Cell Metab 2013;17:901-915
33. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946
34. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008;105:5266-5270
35. Moon YS, Smas CM, Lee K, et al. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 2002;22: 5585-5592
36. Kavalkova P, Touskova V, Roubicek T, et al. Serum preadipocyte factor-1 concentrations in females with obesity and type 2 diabetes mellitus: the influence of very low calorie diet, acute hyperinsulinemia, and fenofibrate treatment. Horm Metab Res 2013;45:820-826
37. Carlsson C, Tornehave D, Lindberg K, et al. Growth hormone and prolactin stimulate the expression of rat preadipocyte factor-1/delta-like protein in pancreatic islets: molecular cloning and expression pattern during development and growth of the endocrine pancreas. Endocrinology 1997;138:3940-3948
38. Tornehave D, Jansen P, Teisner B, Rasmussen HB, Chemnitz J, Moscoso G. Fetal antigen 1 (FA1) in the human pancreas: cell type expression, topological and quantitative variations during development. Anat Embryol (Berl) 1993;187: 335-341
39. Friedrichsen BN, Carlsson C, Møldrup A, et al. Expression, biosynthesis and release of preadipocyte factor-1/delta-like protein/fetal antigen-1 in pancreatic beta-cells: possible physiological implications. J Endocrinol 2003; 176:257-266
40. Chen L, Qanie D, Jafari A, et al. Delta-like 1/fetal antigen-1 (Dlk1/FA1) is a novel regulator of chondrogenic cell differentiation via inhibition of the Akt kinase-dependent pathway. J Biol Chem 2011;286:32140-32149
41. Baladrón V, Ruiz-Hidalgo MJ, Nueda ML, et al. Dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. Exp Cell Res 2005;303:343-359
42. Bray SJ, Takada S, Harrison E, Shen SC, Ferguson-Smith AC. The atypical mammalian ligand Delta-like homologue 1 (Dlk1) can regulate Notch signalling in Drosophila. BMC Dev Biol 2008;8:11
43. Müller D, Cherukuri P, Henningfeld K, et al. Dlk1 promotes a fast motor neuron biophysical signature required for peak force execution. Science 2014; 343:1264-1266
44. Valenti L, Mendoza RM, Rametta R, et al. Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease. Diabetes 2013;62:4052-4062
45. Pajvani UB, Shawber CJ, Samuel VT, et al. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med 2011;17: 961-967
46. Chacón MR, Miranda M, Jensen CH, et al. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro. Int J Obes (Lond) 2008;32:1122-1129
47. Hong SH, Koo JW, Hwang JK, et al. Changes in serum osteocalcin are not associated with changes in glucose or insulin for osteoporotic patients treated with bisphosphonate. J Bone Metab 2013;20:37-41
48. Schwartz AV, Schafer AL, Grey A, et al. Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. J Bone Miner Res 2013;28:1348-1354
49. Flehmig G, Scholz M, Klöting N, et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS One 2014;9:e99785